Advanced search

Role of Caspases in inflammation-driven diseases

Kristof Kersse (UGent) , Tom Vanden Berghe (UGent) , Saskia Lippens (UGent) , Wim Declercq (UGent) and Peter Vandenabeele (UGent)
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Kersse, Kristof, Tom Vanden Berghe, Saskia Lippens, Wim Declercq, and Peter Vandenabeele. 2008. “Role of Caspases in Inflammation-driven Diseases.” In Design of Caspase Inhibitors as Potential Clinical Agents, ed. Tom O’Brien and Steven D. Linton, 19–58. Boca Raton: CRC Press.
APA
Kersse, K., Vanden Berghe, T., Lippens, S., Declercq, W., & Vandenabeele, P. (2008). Role of Caspases in inflammation-driven diseases. In T. O’Brien & S. D. Linton (Eds.), Design of Caspase inhibitors as potential clinical agents (pp. 19–58). Boca Raton: CRC Press.
Vancouver
1.
Kersse K, Vanden Berghe T, Lippens S, Declercq W, Vandenabeele P. Role of Caspases in inflammation-driven diseases. In: O’Brien T, Linton SD, editors. Design of Caspase inhibitors as potential clinical agents. Boca Raton: CRC Press; 2008. p. 19–58.
MLA
Kersse, Kristof, Tom Vanden Berghe, Saskia Lippens, et al. “Role of Caspases in Inflammation-driven Diseases.” Design of Caspase Inhibitors as Potential Clinical Agents. Ed. Tom O’Brien & Steven D. Linton. Boca Raton: CRC Press, 2008. 19–58. Print.
@incollection{674761,
  author       = {Kersse, Kristof and Vanden Berghe, Tom and Lippens, Saskia and Declercq, Wim and Vandenabeele, Peter},
  booktitle    = {Design of Caspase inhibitors as potential clinical agents},
  editor       = {O'Brien, Tom and Linton, Steven D.},
  isbn         = {9781420045406},
  language     = {eng},
  pages        = {19--58},
  publisher    = {CRC Press},
  series       = {Enzyme Inhibitors},
  title        = {Role of Caspases in inflammation-driven diseases},
  year         = {2008},
}